ADVENTIA PHARMA launches 'Permeacare', a new product for increased intestinal permeability
The Spanish pharmaceutical laboratory Adventia Pharma has launched 'Permeacare', a new product for increased intestinal permeability, directly related to different diseases, not only digestive, such as irritable bowel syndrome or inflammatory bowel disease, but also neurological, rheumatological or dermatological . The alteration of the intestinal wall allows toxic substances and microorganisms to cross the intestinal barrier and reach the ...
